Gefitinib for EGFR mutated lung adenocarcinoma during pregnancy: A case report with 5-Year Follow-Up. Messekher M, Fuchs F, Badr M, Pujol JL, et al. Lung Cancer 2025;202:108456.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Messekher M, Fuchs F, Badr M, Pujol JL, et al. Gefitinib for EGFR mutated lung adenocarcinoma during pregnancy: A case report with 5-Year Follow-Up. Lung Cancer 2025;202:108456.
PMID: 40117847